Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell projection, cilium, flagellum Note=Localizes to the principle piece of the sperm flagellum. |
Domain |
PF05716 A-kinase anchor protein 110 kDa (AKAP 110) PF10522 RII binding domain |
Function |
Major structural component of sperm fibrous sheath. Plays a role in sperm motility. |
Biological Process |
GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007338 single fertilization GO:0009566 fertilization GO:0010737 protein kinase A signaling GO:0010738 regulation of protein kinase A signaling GO:0010927 cellular component assembly involved in morphogenesis GO:0030031 cell projection assembly GO:0030317 flagellated sperm motility GO:0042384 cilium assembly GO:0044458 motile cilium assembly GO:0044782 cilium organization GO:0060271 cilium morphogenesis GO:0097722 sperm motility |
Molecular Function |
GO:0051018 protein kinase A binding |
Cellular Component |
GO:0005929 cilium GO:0005952 cAMP-dependent protein kinase complex GO:0030016 myofibril GO:0030017 sarcomere GO:0030018 Z disc GO:0031514 motile cilium GO:0031674 I band GO:0035686 sperm fibrous sheath GO:0036126 sperm flagellum GO:0043292 contractile fiber GO:0044441 ciliary part GO:0044449 contractile fiber part GO:0061695 transferase complex, transferring phosphorus-containing groups GO:0097223 sperm part GO:0097228 sperm principal piece GO:1902554 serine/threonine protein kinase complex GO:1902911 protein kinase complex |
KEGG | - |
Reactome | - |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between AKAP4 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of AKAP4 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of AKAP4 in various data sets.
|
Points in the above scatter plot represent the mutation difference of AKAP4 in various data sets.
|
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of AKAP4. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of AKAP4. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by AKAP4. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of AKAP4. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of AKAP4 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between AKAP4 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | AKAP4 |
Name | A kinase (PRKA) anchor protein 4 |
Aliases | p82; hAKAP82; AKAP82; Fsc1; CT99; A-kinase anchor protein 82 kDa; testis-specific gene HI; protein kinase A ...... |
Chromosomal Location | Xp11.2 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting AKAP4 collected from DrugBank database. |
There is no record. |